Showing results (121-130 of 364) with videos related to
Sort By:
Pageof 37
Cancer Detection and Prevention|January 1, 1988
Effect of phytohemagglutinin and interleukin-2 on malignant and nonmalignant B and T lymphocytesA Porwit, P Panayotides, J Wasserman, et al.European Journal of Haematology|March 1, 1987
Interleukin-2 can induce proliferation of leukemic B-cells in prolymphocytic leukemiaP Panayotides, A Porwit, R Lenkei, et al.Hematological Oncology|July 1, 1989
Absent clinical effects of retinoic acid and isoretinoin treatment in the myelodysplastic syndromeR Hast, S Axdorph, L Laurén, et al.Scandinavian Journal of Haematology|January 1, 1986
Enzyme markers in acute myeloid leukaemiaL Skoog, T Hägerström, P Reizenstein, et al.American Journal of Hematology|August 1, 1993
Variation in DNA content of immature normal bone marrow cellsS Widell, G Auer, R Hast, et al.American Journal of Hematology|March 1, 1993
Comparison of acute myeloid leukemia occurring de novo or preceded by a myelodysplastic stage: differences in cellular DNA contentS Widell, G Auer, R Hast, et al.Anticancer Research|July 1, 1989
Survival, hospitalization and cause of death in 99 patients with the myelodysplastic syndromeK Konstantopoulos, L Lauren, R Hast, et al.Medical Oncology and Tumor Pharmacotherapy|January 1, 1986
Malignant B-cells have receptors for and respond to interleukin-2P Panayotides, R Lenkei, A Porwit, et al.European Journal of Haematology|November 1, 1989
Accumulation of vincristine and doxorubicin in malignant lymphocytes with different immunophenotypesP Reizenstein, R Kapoor, A Gruber, et al.Acta Medica Scandinavica|January 1, 1980
Predicting response to combination chemotherapy in acute myeloblastic leukemia--- a way to individualize treatmentP Reizenstein, N E Giannoulis, N O JohanssonPageof 37